DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

Recruiting now · Not applicable

Conditions studied: Hematologic Malignancies, Lymphoma, Multiple Myeloma, Leukemia, Blood Cancers

In brief

The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.

Key facts

Study ID

NCT06296368

Run by

UNC Lineberger Comprehensive Cancer Center

People needed

500

Starts

2024-06-21

Expected to finish

2028-09-01

Last updated by the study team

2026-08-04

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• All subjects meeting any of the exclusion criteria listed below at baseline will be excluded from study participation:
• Dementia, altered mental status, or psychiatric condition that would prohibit the understanding or rendering of informed consent or participation in the intervention.

Where it is running

• Lineberger Comphrehensive Cancer Center at University of North Carolina — Chapel Hill, North Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.